Synthesis and characterization of novel N-phenylacetamide bearing 1,2,4-triazole derivatives as potential antimicrobial agents

Bochao Li , Xinrui Lin , Yumin Zhang , Dawei Zhang , Yang Xiao , Feng Lin

Chemical Research in Chinese Universities ›› 2017, Vol. 33 ›› Issue (1) : 70 -73.

PDF
Chemical Research in Chinese Universities ›› 2017, Vol. 33 ›› Issue (1) : 70 -73. DOI: 10.1007/s40242-017-6327-3
Article

Synthesis and characterization of novel N-phenylacetamide bearing 1,2,4-triazole derivatives as potential antimicrobial agents

Author information +
History +
PDF

Abstract

A new series of 1-substituted phenyl-2-(1H-1,2,4-triazol-1-yl)ethanone derivatives 3a―3f was synthe-sized and their structures were characterized by IR, 1H NMR, 13C NMR and HRMS spectral analysis. Antimicrobial activities of the derivatives were measured against both bacteria and fungi. In vitro antifungal evaluation showed that five compounds(3b―3f) had growth inhibitory effects on the tested fungus, and three of them(3b, 3c and 3e) showed special efficacy against Gram negative bacteria.

Keywords

N-phenylacetamide / 1,2,4-Triazole / Antibacterial activity / Antifungal activity

Cite this article

Download citation ▾
Bochao Li, Xinrui Lin, Yumin Zhang, Dawei Zhang, Yang Xiao, Feng Lin. Synthesis and characterization of novel N-phenylacetamide bearing 1,2,4-triazole derivatives as potential antimicrobial agents. Chemical Research in Chinese Universities, 2017, 33(1): 70-73 DOI:10.1007/s40242-017-6327-3

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Abdel-Wahab B. F., Abdel-Aziz H. A., Ahmed E. M. Monatsh. Chem., 2009, 140: 601.

[2]

Mathew V., Keshavayyab J., Vaidya V. P. Eur. J. Med. Chem., 2006, 41: 1048.

[3]

Karyotakis N. C., Anaissie E. J. Curr. Opin. Infect. Dis., 1994, 7: 658.

[4]

Plech T., Kapron B., Paneth A., Kosikowska U., Malm A., Strzelczyk A., Staczek P., Swiatek L., Rajtar B., Polz-Dacewicz M. Eur. J. Med. Chem., 2015, 97: 94.

[5]

Ahmed S., Zayed M. F., El-Messery S. M., Al-Agamy M. H., Abdel-Rahman H. M. Molecules, 2016, 21(5): 568.

[6]

Grant S. M., Clissold S. P. Drug, 1990, 39(6): 877.

[7]

Wong-Beringer A., Kriengkauykiat J. Pharmacotherpay, 2003, 23(11): 1441.

[8]

Sun Q. Y., Xu J. M., Cao Y. B., Zhang W. N., Wu Q. Y., Zhang D. Z., Zhang J., Zhao H. Q., Jiang Y. Y. Eur. J. Med. Chem., 2007, 42: 1226.

[9]

Kucukguzel I., Kucukguzel S. G., Rollas S., Kiraz M. Med. Chem. Lett., 2001, 11: 1703.

[10]

Bordie A. Trends Endocrinol Metab., 2002, 13(2): 61.

[11]

Brueggemeier R. W., Hackett J. C., Diaz-Cruz E. S. Endocrine Rev., 2005, 26(3): 331.

[12]

Zhang H. Y., Shi D. Q. J. Heterocyclic Chem., 2014, 51: 344.

[13]

Metwally K. A., Yaseen S. H., Lashine E. M., El-Fayomi H. M., El-Sadek M. E. Eur. J. Med. Chem., 2007, 42(2): 152.

[14]

Kumar H., Javed S. A., Khan S. A., Amir M. Eur. J. Med. Chem., 2008, 43(12): 2688.

[15]

Burlison J. A., Avila C., Vielhauer G., Lubbers D. J., Holzbeierlein J., Blagg B. S. J. Org. Chem., 2008, 73(6): 2130.

[16]

Good J. A., Silver J., Núñez-Otero C., Bahnan W., Krishnan K. S., Salin O., Engström P., Svensson R., Artursson P., Gylfe, Bergström S., Almqvist F. J. Med. Chem., 2016, 59(5): 2094.

[17]

Hu D. Y., Wan H. H., Song Y., Song B. A., Pinaki S., Jin L. H., Yan K., Liu F., Chen Z., Wei X. J. Agric. Food Chem., 2008, 56: 998.

[18]

Oda Y., Sato T., Chida N. Org. Lett., 2012, 14(3): 950.

[19]

Duerfeldt A. S., Brandt G. E., Blagg B. S. Org. Lett., 2009, 11(11): 2353.

[20]

Breugst M., Tokuyasu T., Mayr H. J. Org. Chem., 2010, 75(15): 5250.

[21]

Soleimani A., Drappel S., Carlini R., Goredema A., Gillies E. R. Ind. Eng. Chem. Res., 2014, 53(4): 1452.

[22]

National Committee for Clinical Laboratory Standards, NCCLS Approval Standard Document M2-A7, Vilanova, PA,USA, 2000

[23]

Stankovský, Jedlovská E., Špirková K. Collect. Czech. Chem. Commun., 1993, 58: 2211.

AI Summary AI Mindmap
PDF

110

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/